These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136 [TBL] [Abstract][Full Text] [Related]
3. Successful carboxypeptidase G2 rescue in delayed MTX-elimination due to renal failure. Hum M; Kamen BA Pediatr Hematol Oncol; 1995; 12(6):521-4. PubMed ID: 8588996 [No Abstract] [Full Text] [Related]
4. Glucarpidase for the treatment of life-threatening methotrexate overdose. Tuffaha HW; Al Omar S Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306 [TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy. Krause AS; Weihrauch MR; Bode U; Fleischhack G; Elter T; Heuer T; Engert A; Diehl V; Josting A Leuk Lymphoma; 2002 Nov; 43(11):2139-43. PubMed ID: 12533039 [TBL] [Abstract][Full Text] [Related]
6. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions]. Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010 [TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068 [TBL] [Abstract][Full Text] [Related]
11. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency. Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394 [TBL] [Abstract][Full Text] [Related]